Injective Weekly Analysis
Injective (INJ) has been the biggest gainer of the week with a robust increase of 20.43%. After reaching an all-time high (ATH) of $53.01, INJ experienced a significant sell-off, filling the Fair Value Gap (FVG) on the daily timeframe and touching a low of $18.70 before quickly bouncing back. Currently, INJ is trading within a range of $21.54 to $29, facing multiple rejections around the $29 mark. Despite these rejections, INJ is showing a slight bullish trend, forming higher highs and lower lows. If INJ manages to break out of this range, it could potentially surge to the next resistance level at $34.
On both daily and weekly timeframes, moving averages strongly indicate a bullish signal, while oscillators remain neutral. Fundamentally, INJ is a strong asset to include in a portfolio. It is advisable to consider buying INJ during price dips to take advantage of potential discounts.
On both daily and weekly timeframes, moving averages strongly indicate a bullish signal, while oscillators remain neutral. Fundamentally, INJ is a strong asset to include in a portfolio. It is advisable to consider buying INJ during price dips to take advantage of potential discounts.
עסקה פעילה
INJ has broke the channel and has touched $32.99הערה
Update: Injective announces integration of Paxos and PayPal’s joint stablecoin PPYUSD, becoming one of the first L1 platforms to support the token.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.
כתב ויתור
המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.